CNTB logo

CNTB Stock Overview

Profile

Full Name:

Connect Biopharma Holdings Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

March 19, 2021

Indexes:

Not included

Website:

http://www.connectbiopharm.com

Description:

Connect Biopharma Holdings Limited is a biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. They aim to create effective treatments by targeting specific immune pathways, improving patient outcomes and quality of life. Their research emphasizes advanced drug development and clinical trials.

Key Details

Price

$0.85

Market Cap

$46.97 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$1.08(+49.77% YoY)

PE Ratio

-

Annual ROE

-58.89%

Annual Debt To Equity

0.00

Beta

1.37

Events Calendar

Earnings

Next earnings date:

Apr 16, 2025

Recent quarterly earnings:

Sep 5, 2024

Recent annual earnings:

Apr 16, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 6, 24 HC Wainwright & Co.
Buy
Jun 13, 24 HC Wainwright & Co.
Buy
Apr 17, 24 HC Wainwright & Co.
Buy
Mar 4, 24 HC Wainwright & Co.
Buy
Sep 13, 23 Cantor Fitzgerald
Overweight
Feb 8, 23 SVB Leerink
Outperform
Jun 2, 22 Cantor Fitzgerald
Overweight
May 5, 22 Piper Sandler
Neutral
May 4, 22 SVB Leerink
Outperform
Jan 6, 22 SVB Leerink
Outperform

Screeners with CNTB included

Growing Shares Outstanding
Stocks cheaper than 1 dollar
US stocks
Stocks with high beta
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
NASDAQ Listed Companies

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.85
CNTB price is $0.85

Price All-time High

$28.50
CNTB price is currently -97.02% below its historical high of $28.50

Price Analysts Target

$7.00
CNTB price is currently -87.86% lower than the consensus analysts' forecast

Price Most Recent Change

+2.41%
CNTB price was up +2.41% on Mar 7, 2025

Price YTD Change

-37%
CNTB price is down -37% since January 1st

Price 3-Year Change

-79.86%
CNTB price is down -79.86% over the past 3 years

Market cap

Market Cap

$46.97 M
CNTB market capitalization is $46.97 million

Market Cap 3-Year Change

-79.79%
CNTB market capitalization is down -79.79% over the past 3 years

Market Cap All-time High

$1.64 B
CNTB market capitalization is currently -97.13% below its historical high of $1.64 billion

Market Cap Sector Rank

35.23%
CNTB market capitalization is higher than 35.23% of companies in Healthcare sector

Technical

Beta

1.37
CNTB beta is 1.37

200-day SMA

$1.20
CNTB price is currently -29.30% below its 200-day simple moving average

14-day RSI

42.31
CNTB 14-day relative strength index is 42.31

30-day Relative Volume

0.12
CNTB 30-day relative volume is 0.12

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
CNTB annual revenue value is unknown

Annual Revenue Analysts Estimate

$172.83 M
CNTB annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
CNTB annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
CNTB annual revenue is unknown

Profit

Annual Gross Profit

-
CNTB annual gross profit value is unknown

Annual Gross Margin

-
CNTB annual gross profit margin value is unknown

Annual Operating Profit

-$64.85 M
CNTB annual operating income is -$64.85 million

Annual Operating Margin

-
CNTB annual operating profit margin value is unknown

Annual Net Income

-$59.50 M
CNTB annual net profit is -$59.50 million

Annual Net Margin

-
CNTB annual net profit margin value is unknown

EPS

Annual EPS

-$1.08
CNTB annual earnings per share is -$1.08

Annual EPS Analysts Estimate

-$0.21
CNTB annual earnings per share is currently +402.33% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

+49.77%
CNTB annual earnings per share is up +49.77% year-on-year

Annual EPS Sector Rank

57.6%
CNTB annual earnings per share is higher than 57.6% of companies in Healthcare sector

ROA & ROE

Annual ROA

-47.27%
CNTB annual return on assets is -47.27%

Annual ROE

-58.89%
CNTB annual return on equity is -58.89%

EBIT & EBITDA

Annual EBIT

-$59.36 M
CNTB annual earnings before interest & taxes is -$59.36 million

Annual EBITDA

-$58.37 M
CNTB annual EBITDA is -$58.37 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
CNTB price to earnings ratio value is unknown

PE Ratio Sector Rank

-
CNTB price to earnings ratio is unknown

PB Ratio

PB Ratio

0.43
CNTB price to book ratio is 0.43

PB Ratio Sector Rank

25.86%
CNTB price to book ratio is higher than 25.86% of companies in Healthcare sector

PS Ratio

PS Ratio

-
CNTB price to sales ratio value is unknown

PS Ratio Sector Rank

-
CNTB price to sales ratio is unknown

Enterprise value

Enterprise Value

-$62.88 M
CNTB enterprise value is -$62.88 million

Enterprise Value Sector Rank

1.16%
CNTB enterprise value is higher than 1.16% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
CNTB EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
CNTB EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.99
CNTB annual current ratio is 4.99

Annual Quick Ratio

-
CNTB annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
CNTB annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-2580.87
CNTB annual interest coverage ratio is -2580.87

Risk & Stability

Piotroski F-Score

-
CNTB piotroski f-score value is unknown

Altman Z-Score

-
CNTB altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$125.89 M
CNTB annual total assets is $125.89 million

Annual Non Current Assets

$4.92 M
CNTB annual long term assets is $4.92 million

Annual Current Assets

$120.97 M
CNTB annual total current assets is $120.97 million

Annual Cash & Cash Equivalents

$106.01 M
CNTB annual cash & cash equivalents is $106.01 million

Equity

Annual Book Value

$101.04 M
CNTB annual book value is $101.04 million

Annual Working Capital

$96.71 M
CNTB annual working capital is $96.71 million

Liabilities

Annual Total Liabilities

$24.85 M
CNTB annual total liabilities is $24.85 million

Annual Total Long Term Liabilities

$585.00 K
CNTB annual total long term liabilities is $585.00 thousand

Annual Current Liabilities

$24.26 M
CNTB annual total current liabilities is $24.26 million

Annual Accounts Payable

$7.66 M
CNTB annual accounts payable is $7.66 million

Debt

Annual Total Debt

$465.00 K
CNTB annual total debt is $465.00 thousand

Annual Total Debt 1-Year Change

+7.89%
CNTB annual total debt is up +7.89% year-on-year

Annual Long Term Debt

$180.00 K
CNTB annual long term debt is $180.00 thousand

Annual Short Term Debt

$285.00 K
CNTB annual short term debt is $285.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$64.85 M
CNTB annual total expenses is $64.85 million

Annual Operating Expenses

$64.85 M
CNTB annual total operating expenses is $64.85 million

Annual Cost Of Goods Sold

-
CNTB annual cost of goods sold value is unknown

Annual SGA

$14.52 M
CNTB annual SGA is $14.52 million

Annual D&A

$988.00 K
CNTB annual depreciation & amortization is $988.00 thousand

Annual Interest Expense

$23.00 K
CNTB annual interest expense is $23.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$47.93 M
CNTB annual cash flow from operations is -$47.93 million

Annual CFO 1-Year Change

+52.79%
CNTB annual cash flow from operations is up +52.79% year-on-year

Annual CFI

$75.16 M
CNTB annual cash flow from investing activities is $75.16 million

Annual CFI 1-Year Change

+187.14%
CNTB annual cash flow from investing activities is up +187.14% year-on-year

Annual CFF

-$246.00 K
CNTB annual cash flow from financing activities is -$246.00 thousand

Annual CFF 1-Year Change

-189.41%
CNTB annual cash flow from financing activities is down -189.41% year-on-year

Free CashFlow

Annual FCF

-$48.22 M
CNTB annual free cash flow is -$48.22 million

Annual FCF 1-Year Change

+54.47%
CNTB annual free cash flow is up +54.47% year-on-year

CAPEX

Annual CAPEX

-
CNTB annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
CNTB annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

PDSB logo
PDS Biotechnology (PDSB)
ALGS logo
Aligos Therapeutics (ALGS)
OTLK logo
Outlook Therapeutics (OTLK)
MAIA logo
MAIA Biotechnology (MAIA)
SER logo
Serina Therapeutics (SER)
ICCC logo
ImmuCell (ICCC)
ITRM logo
Iterum Therapeutics (ITRM)
IMRX logo
Immuneering (IMRX)
ATRA logo
Atara Biotherapeutics (ATRA)

FAQ

  • What is the ticker symbol for Connect Biopharma Holdings Limited?
  • Does Connect Biopharma Holdings Limited pay dividends?
  • What sector is Connect Biopharma Holdings Limited in?
  • What industry is Connect Biopharma Holdings Limited in?
  • What country is Connect Biopharma Holdings Limited based in?
  • When did Connect Biopharma Holdings Limited go public?
  • Is Connect Biopharma Holdings Limited in the S&P 500?
  • Is Connect Biopharma Holdings Limited in the NASDAQ 100?
  • Is Connect Biopharma Holdings Limited in the Dow Jones?
  • When was Connect Biopharma Holdings Limited's last earnings report?
  • When does Connect Biopharma Holdings Limited report earnings?
  • Should I buy Connect Biopharma Holdings Limited stock now?

What is the ticker symbol for Connect Biopharma Holdings Limited?

The ticker symbol for Connect Biopharma Holdings Limited is NASDAQ:CNTB

Does Connect Biopharma Holdings Limited pay dividends?

No, Connect Biopharma Holdings Limited does not pay dividends

What sector is Connect Biopharma Holdings Limited in?

Connect Biopharma Holdings Limited is in the Healthcare sector

What industry is Connect Biopharma Holdings Limited in?

Connect Biopharma Holdings Limited is in the Biotechnology industry

What country is Connect Biopharma Holdings Limited based in?

Connect Biopharma Holdings Limited is headquartered in United States

When did Connect Biopharma Holdings Limited go public?

Connect Biopharma Holdings Limited's initial public offering (IPO) was on March 19, 2021

Is Connect Biopharma Holdings Limited in the S&P 500?

No, Connect Biopharma Holdings Limited is not included in the S&P 500 index

Is Connect Biopharma Holdings Limited in the NASDAQ 100?

No, Connect Biopharma Holdings Limited is not included in the NASDAQ 100 index

Is Connect Biopharma Holdings Limited in the Dow Jones?

No, Connect Biopharma Holdings Limited is not included in the Dow Jones index

When was Connect Biopharma Holdings Limited's last earnings report?

Connect Biopharma Holdings Limited's most recent earnings report was on Sep 5, 2024

When does Connect Biopharma Holdings Limited report earnings?

The next expected earnings date for Connect Biopharma Holdings Limited is Apr 16, 2025

Should I buy Connect Biopharma Holdings Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions